CF PharmTech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SHSC:2652 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
01 Apr 26	BuyHK$193,650	Liang Wenqing	Individual	8,500	HK$22.78
23 Dec 25	BuyHK$358,600	Liang Wenqing	Individual	10,500	HK$34.15
19 Dec 25	BuyHK$171,860	Liang Wenqing	Individual	5,000	HK$34.37
18 Dec 25	BuyHK$379,300	Liang Wenqing	Individual	11,000	HK$34.48

Insider Trading Volume

Insider Buying: 2652 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2652?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,246,384	0.303%
VC/PE Firms	26,058,641	6.34%
Institutions	37,719,897	9.18%
Private Companies	84,973,080	20.7%
General Public	261,028,885	63.5%

Dilution of Shares: 2652 only recently listed within the past 12 months

Top Shareholders

Top 12 shareholders own 36.49% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.36%	Pyramid Investment Limited	26,129,045	HK$490.7m	0%	no data
6.34%	SDIC Innovation Investment Management Co., Ltd.	26,058,641	HK$489.4m	0%	3.28%
5.83%	Gentiana International Corporation Limited	23,964,547	HK$450.1m	0%	no data
5.12%	Suzhou Minmei Investment Management Enterprise esop	21,063,828	HK$395.6m	0%	no data
4.7%	Suzhou Yuanchen Enterprise Management Center (Limited Partnership)	19,329,782	HK$363.0m	0%	no data
2.63%	Suzhou Meimin Enterprise Management Center (Limited Partnership)	10,791,401	HK$202.7m	0%	no data
2.57%	Suzhou Wolun Enterprise Management Center esop	10,563,854	HK$198.4m	0%	no data
1.48%	CICC Capital Management Co., Ltd.	6,092,215	HK$114.4m	0%	0.36%
0.81%	Chengdu Boyuan Jiayu Venture Capital Partnership (Limited Partnership)	3,319,747	HK$62.3m	0%	no data
0.35%	Suzhou Shengyuan Enterprise Management Center (Limited Partnership)	1,438,558	HK$27.0m	0%	no data
0.29%	Xiangyun Chen	1,204,884	HK$22.6m	0%	no data
0.01%	Liang Wenqing	41,500	HK$779.6k	25.8%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/21 04:13
End of Day Share Price	2026/06/18 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CF PharmTech, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.